TY - JOUR
T1 - Quality assurance of colonoscopy within the Dutch national colorectal cancer screening program
AU - Dutch Colonoscopy Quality Assurance working group
AU - Bronzwaer, Maxime E. S.
AU - Depla, Annekatrien C. T. M.
AU - van Lelyveld, Niels
AU - Spanier, Bernhard W. M.
AU - Oosterhout, Yvonne H.
AU - van Leerdam, Monique E.
AU - Spaander, Manon C. W.
AU - Dekker, Evelien
AU - van Haastert, M.
AU - Keller, J. J.
AU - Koch, A. D.
AU - Koornstra, J. J.
AU - van Kouwen, M. C. A.
AU - Masclee, A.
AU - Mundt, M. W.
AU - de Ridder, R. J.
AU - van der Sluys-Veer, A.
AU - van Wieren, M.
AU - van Haastert, M.
AU - Keller, J. J.
AU - Koch, A. D.
AU - Koornstra, J. J.
AU - van Kouwen, M. C. A.
AU - Masclee, A.
AU - Mundt, M. W.
AU - de Ridder, R. J.
AU - van der Sluys-Veer, A.
AU - van Wieren, M.
PY - 2019
Y1 - 2019
N2 - Colorectal cancer (CRC) screening is capable of reducing CRC-related morbidity and mortality. Colonoscopy is the reference standard to detect CRC, also providing the opportunity to detect and resect its precursor lesions: colorectal polyps. Therefore, colonoscopy is either used as a primary screening tool or as a subsequent procedure after a positive triage test in screening programs based on non-invasive stool testing or sigmoidoscopy. However, in both settings, colonoscopy is not fully protective for the occurrence of post-colonoscopy CRCs (PCCRCs). Because most PCCRCs are the result of colonoscopy-related factors, a high-quality procedure is of paramount importance to assure optimal effectiveness of CRC screening programs. For this reason, at the start of the Dutch fecal immunochemical test (FIT)-based screening program, quality criteria for endoscopists performing colonoscopies in FIT-positive screenees, as well as for endoscopy centers, were defined. In conjunction, an accreditation and auditing system was designed and implemented. In this report, we describe the quality assurance process for endoscopists participating in the Dutch national CRC screening program, including a detailed description of the evidence-based quality criteria. We believe that our experience might serve as an example for colonoscopy quality assurance programs in other CRC screening programs.
AB - Colorectal cancer (CRC) screening is capable of reducing CRC-related morbidity and mortality. Colonoscopy is the reference standard to detect CRC, also providing the opportunity to detect and resect its precursor lesions: colorectal polyps. Therefore, colonoscopy is either used as a primary screening tool or as a subsequent procedure after a positive triage test in screening programs based on non-invasive stool testing or sigmoidoscopy. However, in both settings, colonoscopy is not fully protective for the occurrence of post-colonoscopy CRCs (PCCRCs). Because most PCCRCs are the result of colonoscopy-related factors, a high-quality procedure is of paramount importance to assure optimal effectiveness of CRC screening programs. For this reason, at the start of the Dutch fecal immunochemical test (FIT)-based screening program, quality criteria for endoscopists performing colonoscopies in FIT-positive screenees, as well as for endoscopy centers, were defined. In conjunction, an accreditation and auditing system was designed and implemented. In this report, we describe the quality assurance process for endoscopists participating in the Dutch national CRC screening program, including a detailed description of the evidence-based quality criteria. We believe that our experience might serve as an example for colonoscopy quality assurance programs in other CRC screening programs.
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85057178414&origin=inward
UR - https://www.ncbi.nlm.nih.gov/pubmed/30240879
U2 - https://doi.org/10.1016/j.gie.2018.09.011
DO - https://doi.org/10.1016/j.gie.2018.09.011
M3 - Article
C2 - 30240879
SN - 0016-5107
VL - 89
SP - 1
EP - 13
JO - Gastrointestinal Endoscopy
JF - Gastrointestinal Endoscopy
IS - 1
ER -